Barclays’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.97M | Buy |
210,877
+121,161
| +135% | +$2.85M | ﹤0.01% | 1633 |
|
|
2025
Q1 | $2.16M | Sell |
89,716
-9,432
| -10% | -$227K | ﹤0.01% | 1977 |
|
|
2024
Q4 | $4.19M | Buy |
99,148
+13,753
| +16% | +$581K | ﹤0.01% | 1732 |
|
|
2024
Q3 | $3.77M | Buy |
85,395
+41,394
| +94% | +$1.83M | ﹤0.01% | 1721 |
|
|
2024
Q2 | $1.59M | Buy |
44,001
+433
| +1% | +$15.7K | ﹤0.01% | 1847 |
|
|
2024
Q1 | $1.88M | Sell |
43,568
-70,179
| -62% | -$3.03M | ﹤0.01% | 1981 |
|
|
2023
Q4 | $1.75M | Buy |
113,747
+42,044
| +59% | +$647K | ﹤0.01% | 2246 |
|
|
2023
Q3 | $983K | Buy |
71,703
+64,968
| +965% | +$891K | ﹤0.01% | 2112 |
|
|
2023
Q2 | $107K | Sell |
6,735
-4,237
| -39% | -$67.3K | ﹤0.01% | 3363 |
|
|
2023
Q1 | $85K | Sell |
10,972
-2,307
| -17% | -$17.9K | ﹤0.01% | 3613 |
|
|
2022
Q4 | $256K | Buy |
13,279
+3,254
| +32% | +$62.7K | ﹤0.01% | 2970 |
|
|
2022
Q3 | $214K | Buy |
10,025
+9,329
| +1,340% | +$199K | ﹤0.01% | 3041 |
|
|
2022
Q2 | $9K | Sell |
696
-1,526
| -69% | -$19.7K | ﹤0.01% | 4360 |
|
|
2022
Q1 | $53K | Buy |
+2,222
| New | +$53K | ﹤0.01% | 3987 |
|